Data as of Aug 01
| +0.16 / +0.94%|
The 5 analysts offering 12-month price forecasts for Insmed Inc have a median target of 30.00, with a high estimate of 51.00 and a low estimate of 25.00. The median estimate represents a +73.91% increase from the last price of 17.25.
The current consensus among 5 polled investment analysts is to Buy stock in Insmed Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.